{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:47:47Z","timestamp":1784767667346,"version":"3.55.0"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.pharmthera.2022.108216","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T10:58:33Z","timestamp":1653130713000},"page":"108216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research"],"prefix":"10.1016","volume":"240","author":[{"given":"Stephanie L.","family":"Bourke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Katrin","family":"Schlag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saoirse Elizabeth","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108216_bb0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bbi.2009.04.001","article-title":"Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation","volume":"23","author":"Alexander","year":"2009","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/jrms.JRMS_859_17","article-title":"Serum levels of serotonin as a biomarker of newly diagnosed fibromyalgia in women: Its relation to the platelet indices","volume":"23","author":"Al-Nimer","year":"2018","journal-title":"Journal of Research in Medical Sciences\u202f: The Official Journal of Isfahan University of Medical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0015","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2147\/JPR.S258433","article-title":"CBD effects on TRPV1 signaling pathways in cultured DRG neurons","volume":"13","author":"Anand","year":"2020","journal-title":"Journal of Pain Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0020","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00213-019-05442-6","article-title":"Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis","volume":"237","author":"Appiah-Kusi","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0025","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4088\/JCP.v67n0807","article-title":"Comorbidity of fibromyalgia and psychiatric disorders","volume":"67","author":"Arnold","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"27","key":"10.1016\/j.pharmthera.2022.108216_bb0030","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/jwh.2017.6622","article-title":"Gender differences in the prevalence of fibromyalgia and in concomitant medical and psychiatric disorders: A National Veterans Health Administration Study","volume":"2002","author":"Arout","year":"2018","journal-title":"Journal of Women\u2019s Health"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbr.2009.07.005","article-title":"Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: Relevance to human stress-associated painful pathologies","volume":"205","author":"Bardin","year":"2009","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0040","first-page":"163","article-title":"Classification of chronic pain for the International Classification of Diseases (ICD-11): results of the 2017 international World Health Organization field testing","author":"Barke","year":"2022","journal-title":"PAIN"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0045","doi-asserted-by":"crossref","first-page":"13667","DOI":"10.1038\/s41598-019-49403-7","article-title":"No evidence for altered plasma NGF and BDNF levels in fibromyalgia patients","volume":"9","author":"Baumeister","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020577","article-title":"Metabolic syndrome, depression, and fibromyalgia syndrome prevalence in patients with irritable bowel syndrome: A case-control study","volume":"99","author":"Bayrak","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0055","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/hmg\/ddn089","article-title":"Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations","volume":"17","author":"Benzinou","year":"2008","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0065","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of Cannabidiol in neurological disorders","volume":"12","author":"Ibeas","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2022.108216_bib936","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0070","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.21037\/apm.2017.08.05","article-title":"A selective review of medical cannabis in cancer pain management","volume":"6","author":"Blake","year":"2017","journal-title":"Annals of Palliative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0075","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173107","article-title":"Sex differences and the endocannabinoid system in pain","volume":"202","author":"Blanton","year":"2021","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.physbeh.2015.07.033","article-title":"Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats","volume":"151","author":"Blasco-Serra","year":"2015","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0090","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jpain.2021.04.011","article-title":"Substituting Cannabidiol for opioids and pain medications among individuals with fibromyalgia: A large online survey","volume":"22","author":"Boehnke","year":"2021","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151116","article-title":"Morphological alterations in gastrocnemius and soleus muscles in male and female mice in a fibromyalgia model","volume":"11","author":"Bonaterra","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"European Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2310\/JIM.0b013e31824963d1","article-title":"Prevalence of fibromyalgia syndrome in patients referred to a tertiary pain clinic","volume":"60","author":"Brill","year":"2012","journal-title":"Journal of Investigative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/08964289.2019.1683712","article-title":"Perceived efficacy of medical Cannabis in the treatment of co-occurring health-related quality of life symptoms","volume":"47","author":"Bruce","year":"2021","journal-title":"Behavioral Medicine"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0115","article-title":"Animal models of fibromyalgia: What is the best choice?","volume":"107959","author":"Da Silva","year":"2021","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/fampra\/14.3.238","article-title":"Awareness of diagnostic and clinical features of fibromyalgia among family physicians","volume":"14","author":"Buskila","year":"1997","journal-title":"Family Practice"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2826.2008.01689.x","article-title":"A saturated N-Acylethanolamine other than N-Palmitoyl ethanolamine with anti-inflammatory properties: A neglected story\u2026","volume":"20","author":"Dalle","year":"2008","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2022.108216_bib933","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/pm\/pnaa303","article-title":"Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","volume":"21","author":"Chaves","year":"2020","journal-title":"Pain Medicine"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1472-6963-10-102","article-title":"A patient survey of the impact of fibromyalgia and the journey to diagnosis","volume":"10","author":"Choy","year":"2010","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.10103","article-title":"Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits","volume":"46","author":"Cohen","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0140","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1111\/bph.12746","article-title":"Activation of GPR18 by cannabinoid compounds: A tale of biased agonism","volume":"171","author":"Console-Bram","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0145","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.comppsych.2012.03.008","article-title":"The impact of mood, anxiety, and sleep disorders on fibromyalgia","volume":"53","author":"Consoli","year":"2012","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0150","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.medcli.2010.05.009","article-title":"Low levels of serotonin in serum correlates with severity of fibromyalgia","volume":"135","author":"Cordero","year":"2010","journal-title":"Medicina Cl\u00ednica"},{"issue":"6604","key":"10.1016\/j.pharmthera.2022.108216_bib940","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0155","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/apt.13958","article-title":"Randomised clinical trial: The analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome","volume":"45","author":"Cremon","year":"2017","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.31887\/DCNS.2020.22.3\/mcrocq","article-title":"History of cannabis and the endocannabinoid system","volume":"22","author":"Crocq","year":"2020","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0170","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0175","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"De","year":"2020","journal-title":"Pharmacology Research & Perspectives"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0180","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ejpain.2011.02.005","article-title":"Enhanced cytokine-induced mechanical hyperalgesia in skeletal muscle produced by a novel mechanism in rats exposed to unpredictable sound stress","volume":"15","author":"Dina","year":"2011","journal-title":"European Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0185","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0190","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1113\/jphysiol.2002.026559","article-title":"Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel \u03b1 subunit protein","volume":"546","author":"Djouhri","year":"2003","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0195","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.22485","article-title":"Gain of function Nav1. 7 mutations in idiopathic small fiber neuropathy","volume":"71","author":"Faber","year":"2012","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0205","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jpain.2012.08.001","article-title":"Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome","volume":"13","author":"Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2012","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10072-014-1772-y","article-title":"Sex-related differences in migraine","volume":"35","author":"Finocchi","year":"2014","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/keg075","article-title":"Inaccuracy in the diagnosis of fibromyalgia syndrome: Analysis of referrals","volume":"42","author":"Fitzcharles","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00482-015-0084-3","article-title":"Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis)","volume":"30","author":"Fitzcharles","year":"2016","journal-title":"Der Schmerz"},{"issue":"130","key":"10.1016\/j.pharmthera.2022.108216_bb0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.55563\/clinexprheumatol\/qcyet7","article-title":"Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: A cross-sectional study","volume":"39","author":"Fitzcharles","year":"2021","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108216_bib939","doi-asserted-by":"crossref","first-page":"e18440","DOI":"10.1371\/journal.pone.0018440","article-title":"Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life","volume":"6","author":"Fiz","year":"2011","journal-title":"PLOS One"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0230","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/add.15253","article-title":"Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: Systematic review and meta-analysis","volume":"116","author":"Freeman","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0235","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/pmic.200700928","article-title":"Involvement of post-translational modification of neuronal plasticity-related proteins in hyperalgesia revealed by a proteomic analysis","volume":"8","author":"Fujisawa","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0240","doi-asserted-by":"crossref","unstructured":"Gaisey, & Narouze. (2021). Dronabinol (Marinol\u00ae) S. N. Narouze Cannabinoids and pain (105\u2013107). Cham: Springer International Publishing.","DOI":"10.1007\/978-3-030-69186-8_14"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0245","series-title":"Psychology research and behavior management","first-page":"117","article-title":"Psychological impact of fibromyalgia: Current perspectives","volume":"Vol. 12","author":"Galvez-S\u00e1nchez","year":"2019"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0250","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0031-9384(97)00520-9","article-title":"The effects of acute and repeated restraint stress on the nociceptive response in rats","volume":"63","author":"Gamaro","year":"1998","journal-title":"Physiology & Behavior"},{"issue":"Suppl. 130","key":"10.1016\/j.pharmthera.2022.108216_bb0260","doi-asserted-by":"crossref","first-page":"144","DOI":"10.55563\/clinexprheumatol\/bq7x9n","article-title":"A family-based study to identify genetic biomarkers of fibromyalgia: Consideration of patients\u2019 subgroups","volume":"39","author":"Gerra","year":"2021","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0265","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/mus.24156","article-title":"Small nerve fiber involvement in patients referred for fibromyalgia","volume":"49","author":"Giannoccaro","year":"2014","journal-title":"Muscle & Nerve"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0270","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1002\/art.11272","article-title":"Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors","volume":"48","author":"Giesecke","year":"2003","journal-title":"Arthritis and Rheumatism"},{"issue":"123","key":"10.1016\/j.pharmthera.2022.108216_bib932","first-page":"53","article-title":"Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study","volume":"38","author":"Giorgi","year":"2020","journal-title":"Clinical Experimental Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0275","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0280","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.pain.2013.07.047","article-title":"Fatigue-enhanced hyperalgesia in response to muscle insult: Induction and development occur in a sex-dependent manner","volume":"154","author":"Gregory","year":"2013","journal-title":"PAIN"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0285","first-page":"9","article-title":"Some prospective alternatives for treating pain: The endocannabinoid system and its putative receptors GPR18 and GPR55","author":"Guerrero-Alba","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RHU.0000000000000702","article-title":"Medical Cannabis for the treatment of fibromyalgia","volume":"24","author":"Habib","year":"2018","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0295","series-title":"Natural Product Reports","first-page":"1357","article-title":"Phytocannabinoids: A unified critical inventory","volume":"Vol. 33","author":"Hanu\u0161","year":"2016"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0300","series-title":"Cannabinoids and pain","first-page":"109","article-title":"Nabilone (Cesamet)","author":"Harrison","year":"2021"},{"issue":"Suppl. 116","key":"10.1016\/j.pharmthera.2022.108216_bb0305","first-page":"90","article-title":"Fibromyalgia syndrome: under-, over- and misdiagnosis","volume":"37","author":"H\u00e4user","year":"2019","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0310","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical, and sexual abuse in fibromyalgia syndrome: A systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0315","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.braindev.2018.03.013","article-title":"Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents \u2013 An observational, longitudinal study","volume":"40","author":"Hausman-Kedem","year":"2018","journal-title":"Brain and Development"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0320","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/gut.2008.157594","article-title":"Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat","volume":"58","author":"Hong","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0325","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.gastro.2010.11.003","article-title":"Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat. In","volume":"140","author":"Hong","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0330","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1073\/pnas.0409888102","article-title":"CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids","volume":"102","author":"Ibrahim","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0335","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5001\/omj.2012.44","article-title":"Fibromyalgia syndrome: An overview of pathophysiology, diagnosis and management","volume":"27","author":"Jahan","year":"2012","journal-title":"Oman Medical Journal"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0340","series-title":"Progress in Neurobiology","first-page":"1","article-title":"Stress-induced hyperalgesia","volume":"Vol. 121","author":"Jennings","year":"2014"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0345","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pnpbp.2015.05.008","article-title":"Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains","volume":"64","author":"Jennings","year":"2016","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0350","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.brainres.2019.03.014","article-title":"Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors","volume":"1715","author":"Jesus","year":"2019","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0355","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0360","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/jgh.12513","article-title":"Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome","volume":"29","author":"Jiang","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0365","first-page":"89","article-title":"Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia HHS Public Access Author manuscript","volume":"34","author":"Jones","year":"2016","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0370","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2009.06.021","article-title":"Variations in the cannabinoid receptor 1 gene predispose to migraine","volume":"461","author":"Juhasz","year":"2009","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0375","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/clpt.2010.318","article-title":"Subjective and physiological effects after controlled Sativex and oral THC administration","volume":"89","author":"Karschner","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0380","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.psyneuen.2008.02.009","article-title":"Anandamide and neutrophil function in patients with fibromyalgia","volume":"33","author":"Kaufmann","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0385","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2019.05.012","article-title":"Ameliorative effect of imperatorin in chemically induced fibromyalgia: Role of NMDA\/NFkB mediated downstream signaling","volume":"166","author":"Kaur","year":"2019","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0390","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0031-9384(97)00248-5","article-title":"Effects of repeated cold stress on feeding, avoidance behavior, and pain-related nerve fiber activity","volume":"62","author":"Kawanishi","year":"1997","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0395","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/NDT.S99160","article-title":"Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia","volume":"12","author":"Kayhan","year":"2016","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0400","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jpain.2009.04.005","article-title":"Sound stress\u2013induced long-term enhancement of mechanical hyperalgesia in rats is maintained by sympathoadrenal catecholamines","volume":"10","author":"Khasar","year":"2009","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0405","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5056\/jnm18082","article-title":"Sex-gender differences in irritable bowel syndrome","volume":"24","author":"Kim","year":"2018","journal-title":"Journal of Neurogastroenterology and Motility"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0415","doi-asserted-by":"crossref","first-page":"173194","DOI":"10.1016\/j.ejphar.2020.173194","article-title":"ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain. In","volume":"881","author":"Kiso","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0420","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semarthrit.2020.10.006","article-title":"The prevalence of psychiatric and chronic pain comorbidities in fibromyalgia: An ACTTION systematic review","volume":"51","author":"Kleykamp","year":"2021","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0425","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2982.2010.01587.x","article-title":"The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients","volume":"23","author":"Klooker","year":"2011","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0430","doi-asserted-by":"crossref","DOI":"10.1177\/24705470211011075","article-title":"Cannabinoid receptor 1 rs1049353 variant, childhood abuse, and the heterogeneity of PTSD symptoms: Results from the National Health and resilience in veterans study","volume":"5","author":"Korem","year":"2021","journal-title":"Chronic Stress"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0435","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2014.09.035","article-title":"Reduction of Intraepidermal nerve Fiber density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study","volume":"347","author":"Kosmidis","year":"2014","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0440","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ejp.1147","article-title":"Availability and approval of cannabis-based medicines for chronic pain management and palliative\/supportive care in Europe: A survey of the status in the chapters of the European pain federation","volume":"22","author":"Krcevski-Skvarc","year":"2018","journal-title":"European Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0445","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/FBP.0000000000000023","article-title":"Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats","volume":"25","author":"Kwilasz","year":"2014","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0450","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0455","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0460","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchemneu.2018.12.011","article-title":"Serotonergic dysfunction in a model of parkinsonism induced by reserpine","volume":"96","author":"Leal","year":"2019","journal-title":"Journal of Chemical Neuroanatomy"},{"issue":"142","key":"10.1016\/j.pharmthera.2022.108216_bb0465","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2011.0137","article-title":"Temporomandibular disorder and comorbid pain conditions","volume":"1939","author":"Lim","year":"2011","journal-title":"Journal of the American Dental Association"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0470","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41598-020-79349-0","article-title":"Salivary cortisol is associated with cognitive changes in patients with fibromyalgia","volume":"11","author":"Lin","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0475","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/npp.2014.198","article-title":"Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain","volume":"40","author":"Lomazzo","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0480","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/ajmg.b.30693","article-title":"Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. American journal of medical genetics","volume":"147B","author":"Lu","year":"2008","journal-title":"Part B, Neuropsychiatric Genetics : the official publication of the International Society of Psychiatric Genetics"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0485","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated Cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Frontiers in Psychology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0490","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s42238-021-00060-6","article-title":"Medical cannabis for the treatment of fibromyalgia syndrome: A retrospective, open-label case series","volume":"3","author":"Mazza","year":"2021","journal-title":"Journal of Cannabis Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0495","doi-asserted-by":"crossref","DOI":"10.1155\/2005\/242516","article-title":"Pharmacokinetics of cannabinoids","volume":"10","author":"McGilveray","year":"2005","journal-title":"Pain Research & Management"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0500","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of Cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0505","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrn3360","article-title":"Sex differences in pain and pain inhibition: Multiple explanations of a controversial phenomenon","volume":"13","author":"Mogil","year":"2012","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0510","series-title":"Progress in the Chemistry of Organic Natural Products","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-319-45541-9_4","article-title":"Molecular targets of the phytocannabinoids: a complex picture","volume":"103","author":"Morales","year":"2017"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0515","doi-asserted-by":"crossref","first-page":"e1622","DOI":"10.4088\/JCP.15l10084","article-title":"The rs1049353 polymorphism in the CNR1 gene interacts with childhood abuse to predict posttraumatic threat symptoms","volume":"76","author":"Mota","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0520","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2019","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0525","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0530","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","article-title":"Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia","volume":"146","author":"Nagakura","year":"2009","journal-title":"PAIN"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0535","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/24708593.2016.1273986","article-title":"Recent advancements in animal models of fibromyalgia","volume":"23","author":"Nagakura","year":"2015","journal-title":"MYOPAIN"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0540","doi-asserted-by":"crossref","first-page":"172716","DOI":"10.1016\/j.ejphar.2019.172716","article-title":"Spontaneous pain-associated facial expression and efficacy of clinically used drugs in the reserpine-induced rat model of fibromyalgia. In","volume":"864","author":"Nagakura","year":"2019","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0545","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejpain.2009.05.009","article-title":"Persistent deep mechanical hyperalgesia induced by repeated cold stress in rats","volume":"14","author":"Nasu","year":"2010","journal-title":"European Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0550","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/pm\/pnx114","article-title":"Evidence of altered trigeminal nociception in an animal model of fibromyalgia","volume":"19","author":"Nazeri","year":"2017","journal-title":"Pain Medicine"},{"issue":"69","key":"10.1016\/j.pharmthera.2022.108216_bib935","article-title":"Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants","volume":"7","author":"Nishiyori","year":"2011","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0555","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-4-52","article-title":"Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia","volume":"4","author":"Nishiyori","year":"2008","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0560","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuint.2013.01.001","article-title":"Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety","volume":"62","author":"Nugraha","year":"2013","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0565","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"PAIN\u00ae"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0570","first-page":"9","article-title":"Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers","volume":"9","author":"Oh","year":"2017","journal-title":"Clinical Pharmacology : Advances and Applications"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0575","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1254\/jjp.57.243","article-title":"Mechanism of hyperalgesia in SART stressed (repeated cold stress) mice: Antinociceptive effect of neurotropin","volume":"57","author":"Ohara","year":"1991","journal-title":"The Japanese Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0580","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0896-6273(01)00247-1","article-title":"Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals","volume":"29","author":"Ohno-Shosaku","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0585","first-page":"20","article-title":"Neurobiology of stress-induced hyperalgesia","author":"Olango","year":"2014","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0590","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","article-title":"Cannabinoids go nuclear: Evidence for activation of peroxisome proliferator-activated receptors","volume":"152","author":"O\u2019Sullivan","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0595","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0600","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MCG.0b013e3181dd1573","article-title":"Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: A hypothesis-generating study","volume":"45","author":"Park","year":"2011","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0605","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.106.101287","article-title":"Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling","volume":"318","author":"Patel","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0610","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026581","article-title":"Bidirectional association between migraine and fibromyalgia: Retrospective cohort analyses of two populations","volume":"9","author":"Penn","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0615","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.57.7.1326","article-title":"Fibromyalgia is common in patients with transformed migraine","volume":"57","author":"Peres","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0620","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.rcreue.2020.01.004","article-title":"Neuropsychiatric comorbidity in patients with fibromyalgia","volume":"27","author":"Henao","year":"2020","journal-title":"Revista Colombiana de Reumatolog\u00eda (English Edition)"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0625","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical aspects affecting Cannabidiol Oral bioavailability and metabolic elimination, and related clinical implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0635","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0091-3057(00)00374-9","article-title":"Long-lasting delayed hyperalgesia after subchronic swim stress","volume":"67","author":"Quintero","year":"2000","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0640","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2016.05.011","article-title":"Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia - A controlled cross-sectional study","volume":"84","author":"Ranzolin","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0645","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0650","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12529-010-9097-6","article-title":"Fibromyalgia syndrome is associated with hypocortisolism","volume":"17","author":"Riva","year":"2010","journal-title":"International Journal of Behavioral Medicine"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0655","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cpt197722185","article-title":"Physiologic disposition of nabilone, a cannabinol derivative, in man","volume":"22","author":"Rubin","year":"1977","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0660","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780350509","article-title":"Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis","volume":"35","author":"Russell","year":"1992","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0665","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/art.1780371106","article-title":"Elevated cerebrospinal fluid levels of substance p in patients with the fibromyalgia syndrome","volume":"37","author":"Russell","year":"1994","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0670","first-page":"31","article-title":"Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?","volume":"25","author":"Russo","year":"2004","journal-title":"Neuro Endocrinology Letters"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0675","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0680","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1744-8069-5-59","article-title":"Dynamic regulation of the endocannabinoid system: Implications for analgesia","volume":"5","author":"Sagar","year":"2009","journal-title":"Molecular Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0685","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/jcm8060807","article-title":"Safety and efficacy of medical Cannabis in fibromyalgia","volume":"8","author":"Sagy","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0690","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpain.2007.05.002","article-title":"Increased levels of Neurotrophins are not specific for chronic migraine: Evidence from primary fibromyalgia syndrome","volume":"8","author":"Sarchielli","year":"2007","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0695","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: An update on clinical characteristics, aetiopathogenesis and treatmen","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0700","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0704297","article-title":"Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes","volume":"134","author":"Savinainen","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108216_bib934","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ejp.1043","article-title":"Chronic stress-induced mechanical hyperalgesia is controlled by capsaicin-sensitive neurones in the mouse","volume":"21","author":"Scheich","year":"2017","journal-title":"European Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0705","series-title":"Current Medical Research and Opinion","first-page":"1269","article-title":"Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief","volume":"22","author":"Schley","year":"2006"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0710","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ana.24065","article-title":"Hyperexcitable C nociceptors in fibromyalgia","volume":"75","author":"Serra","year":"2014","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0715","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5056\/jnm.2010.16.3.281","article-title":"The role of peripheral cannabinoid receptors type 1 in rats with visceral hypersensitivity induced by chronic restraint stress","volume":"16","author":"Shen","year":"2010","journal-title":"Journal of Neurogastroenterology and Motility"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0720","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia. In","volume":"9","author":"Skrabek","year":"2008","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0725","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0304-3959(03)00269-0","article-title":"Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1","volume":"106","author":"Sluka","year":"2003","journal-title":"PAIN"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0730","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8","article-title":"Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia","volume":"24","author":"Sluka","year":"2001","journal-title":"Muscle & Nerve"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0735","series-title":"Arthritis and Rheumatism","first-page":"584","article-title":"Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia","volume":"Vol. 64","author":"Smith","year":"2012"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187926","article-title":"Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans","volume":"12","author":"Smith","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0745","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/bs.apha.2017.05.003","article-title":"Cannabinoids and pain: Sites and mechanisms of action","volume":"80","author":"Starowicz","year":"2017","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0750","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcp.2004.08.033","article-title":"Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor","volume":"69","author":"Steffens","year":"2005","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0755","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0760","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jpain.2018.05.008","article-title":"The relationship of Endocannabinoidome lipid mediators with pain and psychological stress in women with fibromyalgia: A case-control study","volume":"19","author":"Stensson","year":"2018","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0765","series-title":"Medicine and Science in Sports and Exercise","first-page":"1617","article-title":"Increased anandamide and decreased pain and depression after exercise in fibromyalgia","volume":"52","author":"Stensson","year":"2020"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0770","series-title":"Lipids in Health and Disease","first-page":"1","article-title":"Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - A case control study","volume":"Vol. 16","author":"Stensson","year":"2017"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0775","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pain.2007.03.008","article-title":"Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain","volume":"133","author":"Suard\u00edaz","year":"2007","journal-title":"PAIN\u00ae"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0780","doi-asserted-by":"crossref","first-page":"E1469","DOI":"10.1152\/ajpendo.00269.2012","article-title":"Regulation of GPR119 receptor activity with endocannabinoid-like lipids","volume":"303","author":"Syed","year":"2012","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0785","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/bph.14440","article-title":"Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors","volume":"176","author":"Tham","year":"2019","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0790","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1073\/pnas.94.4.1527","article-title":"Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons","volume":"94","author":"Toledo-Aral","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0795","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0168-0102(02)00232-8","article-title":"Long-lasting delayed hyperalgesia after chronic restraint stress in rats-effect of morphine administration","volume":"45","author":"Da Silva","year":"2003","journal-title":"Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0800","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review","volume":"323","author":"Tram\u00e8r","year":"2001","journal-title":"Bmj"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0815","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/art.24000","article-title":"A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome","volume":"59","author":"\u00dc\u00e7eyler","year":"2008","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0820","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"van de Donk","year":"2019","journal-title":"PAIN"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0825","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0830","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.genhosppsych.2009.07.002","article-title":"Axis I and Axis II psychiatric disorders in patients with fibromyalgia","volume":"32","author":"Uguz","year":"2010","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0835","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2474-13-23","article-title":"A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia","volume":"13","author":"Vargas-Alarcon","year":"2012","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0840","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: A population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0845","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neures.2019.12.015","article-title":"Peripheral nociceptive mechanisms in an experimental rat model of fibromyalgia induced by repeated cold stress","volume":"162","author":"Wakatsuki","year":"2021","journal-title":"Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0850","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.1983.179","article-title":"Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women","volume":"34","author":"Wall","year":"1983","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108216_bib937","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0860","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2017.10.007","article-title":"In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor","volume":"815","author":"Watabiki","year":"2017","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108216_bib938","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/827290","article-title":"Tetrahydrocannabinol (Delta 9-THC) treatment in chronic central neuropathic pain and fibromyalgia patients: Results of a multicenter survey","author":"Weber","year":"2009","journal-title":"Anesthesiology Research and Practice"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0865","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/gast.2002.32392","article-title":"Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?","volume":"122","author":"Whitehead","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0870","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey","year":"2013","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0875","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: Results from a survey of the general population","volume":"65","author":"Wolfe","year":"2013","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0880","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0885","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0890","first-page":"555","article-title":"Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population","volume":"24","author":"Wolfe","year":"1997","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0895","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0900","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1053\/j.gastro.2011.07.036","article-title":"Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome","volume":"141","author":"Wong","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0905","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2982.2011.01874.x","article-title":"Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea","volume":"24","author":"Wong","year":"2012","journal-title":"Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0910","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11011-013-9404-4","article-title":"Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: Behavioral and neurobiological analyses","volume":"28","author":"Xu","year":"2013","journal-title":"Metabolic Brain Disease"},{"issue":"116","key":"10.1016\/j.pharmthera.2022.108216_bib931","first-page":"13","article-title":"Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study.","volume":"37","author":"Yassin","year":"2019","journal-title":"Clinical Experimental Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0915","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/gut.2003.035451","article-title":"Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women","volume":"53","author":"Yeo","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0920","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/j.pain.0000000000002291","article-title":"Prevalence of chronic pain among adults in the United States","volume":"163","author":"Yong","year":"2022","journal-title":"PAIN"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0925","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108216_bb0930","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.biopsych.2006.12.004","article-title":"CNR1 variation modulates risk for drug and alcohol dependence","volume":"62","author":"Zuo","year":"2007","journal-title":"Biological Psychiatry"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:24:12Z","timestamp":1759011852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":190,"alternative-id":["S0163725822001103"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108216","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108216"}}